Equity Tips by
-
Upload
money-capitalheight-research-pvt-ltd -
Category
Documents
-
view
213 -
download
0
description
Transcript of Equity Tips by
Daily Newsletter17/05/2011
Daily Newsletter-Equity
www.capitalheight.com
ww.capitalheight.com
www.capitalheight.com
capitalheight.wordpress.com
Phone- (0731)4295950
MARKET WRAP
Indian market ended down 0.90%; Nifty down 46 pts & Sensex down 187 pts.
April inflation came at 9.04 vs. 8.98% m/m, primary article inflation at 12.05%.
European markets were in red with DAX worst, Dow future was down 6 pts.
Indian market ended down 0.90% due to hike in petrol price & poor WPI inflation data.
Nifty lost 46 pts to end at 5499 while Sensex was down by 187 pts to settle at 18345.
Euro markets were in red with FTSE down 53 pts, CAC down 54 pts & DAX down 100
pts at 7304 as Italian trade balance came down at (-) 3.94b. Dow future was down 6 pts.
MARKET PERFORMANCE
NIFTY GAINERS COMPANY NAME CURRENT PREV. CLOSE(RS) CANG.(RS) CHAG.(%)
Ranbaxy 518.10 490.15 5.70 27.95
Hero Honda 1862.85 1798.00 3.61 64.85
Sun Pharma 440.45 427.30 3.08 13.15
Ambuja 139.30 136.25 2.24 3.05
Sesa Goa 300.40 297.00 1.14 3.40
NIFTY LOSERS
COMPANY NAME CURRENT PREV. CLOSE(RS) CANG.(RS) CHAG.(%)
JP Associate 84.65 87.45 -3.20 -2.80
Siemens 846.55 872.70 -3.00 -26.15
DLF 226.20 232.95 -2.90 -6.75
BajajAuto 1299.65 1336.60 -2.76 -36.95
Tata Steel 577.80 594.00 -2.73 -16.20
www.capitalheight.com
capitalheight.wordpress.com
Phone- (0731)4295950
SECTORIAL INDICES
INDEX P.CLOSE OPEN HIGH LOW LAST % CHANGE
S&P CNX NIFTY 5544.75 5541.70 5541.80 5487.65 5499.00 -0.83
CNX NIFTY JUNIOR
11185.40 11191.35 11204.70 11108.20 11145.60 -0.36
CNX IT 6609.55 6601.05 6615.90 6558.40 6564.05 -0.69
BANK NIFTY 11020.95 10975.15 10975.15 10878.65 10912.35 -0.99
INDIA VIX 20.63 20.63 21.97 19.90 21.46 4.02
CNX 100 5465.45 5462.90 5462.90 5413.90 5424.55 -0.75
S&P CNX DEFTY 4280.25 4261.90 4261.90 4215.65 4221.75 -1.37
S&P CNX 500 4470.35 4469.00 4469.00 4429.50 4436.10 -0.77
CNX MIDCAP 8034.90 8039.10 8047.00 7969.45 7977.70 -0.71
NIFTY MIDCAP 50 2496.65 2493.65 2501.10 2475.65 2480.85 -0.63
CNX INFRA 2923.60 2925.20 2931.05 2905.30 2910.65 -0.44
CNX REALTY 289.20 288.40 288.40 283.50 284.25 -1.71
CNX ENERGY 8916.15 8940.70 8944.90 8839.65 8849.85 -0.74
CNX FMCG 9619.15 9643.80 9674.10 9487.30 9507.45 -1.16
CNX MNC 4977.00 4974.40 5006.60 4954.75 4982.15 0.10
CNX PHARMA 4607.55 4608.35 4682.90 4608.35 4660.05 1.14
CNX PSE 3502.20 3512.85 3526.20 3465.70 3472.25 -0.86
CNX PSU BANK 4145.60 4140.20 4140.20 4085.55 4105.10 -0.98
CNX SERVICE 6686.90 6672.45 6672.45 6615.50 6626.65 -0.90
www.capitalheight.com
capitalheight.wordpress.com
Phone- (0731)4295950
NSE STATS
ADVANCES 14
DECLINES 36
UNCHANGED 0
INDEX MOVERS (PULLING IT UP)
COMPANY NAME CONTRIBUTION
Hero Honda 2.06
Sun Pharma 1.64
Ranbaxy 1.42
Airtel 1.39
BHEL 1.03
INDEX MOVERS (PULLING IT DOWN)
COMPANY NAME CONTRIBUTION
Hindalco -1.30
Siemens -1.33
Dr Reddy -1.39
BajajAuto -1.65
RIL -1.70
VOLUME SHOCKERS
Company Name Last Price % Chg Last Volume Prev Volume % Chg
Dalmia Enter 168.10 -1.15 177851.00 2289.00 7670.00
Halonix 104.65 18.92 198865.00 2829.00 6930.00
Mahindra Holida 369.00 -2.55 303213.00 5142.00 5797.00
Ajanta Pharma 274.60 7.04 1098746.00 24416.00 4400.00
Ganesh Housing 135.65 6.43 345721.00 9868.00 3403.00
www.capitalheight.com
capitalheight.wordpress.com
Phone- (0731)4295950
FII TRADING ACTIVITY (NSE & BSE) In Crores
CATEGORY DATE BUY VALUE SELL VALUE NET VALUE
FII 16-MAY-2011 1854.03 1806.96 47.07
DII TRADING ACTIVITY (NSE & BSE) In Crores
CATEGORY DATE BUY VALUE SELL VALUE NET VALUE
DII 16-MAY-2011 752.71 749.30 3.41
F&O TRADE STATISTICS
PRODUCT NO OF CONTRACTS TURNOVER IN RS. CR. PUT CALL RATIO
Index Futures 420252.00 10751.20 -
Stock Futures 435707.00 11180.20 -
Index Options 2659968.00 74370.17 0.87
Stock Options 108310.00 2970.66 0.45
F&O Total 3624237.00 99272.23 0.85
ASIAN MARKETS
Name Open High Low Current Value Change % Chg
Nikkei 225 9,571.13 9,598.33 9,552.86 9,558.30 -90.47 -0.95
Hang Seng 23,054.06 23,134.64 22,937.14 23,000.09 -276.18 -1.20
Taiwan 8,996.70 8,996.70 8,911.71 8,911.71 -94.90 -1.06
KOSPI 2,104.67 2,115.25 2,097.16 2,104.18 -15.90 -0.76
Jakarta 3,831.93 3,831.93 3,787.66 3,795.24 -36.78 -0.97
TECHNICAL
DAILY PIVOT
SCRIPT R4 R3
NIFTY 5674 5619
OUTLOOK
Trend: - Consolidate
Resistance: - 5540, 5620
Support: - 5440, 5360
Strategy: - Sell on highs
ECHNICAL VIEW
NIFTY
R2 R1 P S1 S2
5564 5532 5509 5477 5454
Consolidate
5540, 5620
5440, 5360
Sell on highs
NIFTY DAILY
www.capitalheight.com
capitalheight.wordpress.com
Phone- (0731)4295950
S2 S3 S4
5454 5399 5344
DAILY PIVOT
SCRIPT R4 R3
BANK NIFTY 11314 11175
OUTLOOK
Trend: - Consolidate
Resistance: - 11050, 11250
Support: - 10700, 10410
Strategy: - Sell on highs
BANK NIFTY
R2 R1 P S1 S2
11175 11036 10954 10897 10815 10758
Consolidate
11050, 11250
10700, 10410
Sell on highs
BANK NIFTY DAILY
www.capitalheight.com
capitalheight.wordpress.com
Phone- (0731)4295950
S2 S3 S4
10758 10619 10480
Stock
CapitalHeight’s stock recommendation for
Ranbaxy is in uptrend for a week now and today ended up more than 5% at 518.10.
The stock is close to its 200 DMA at around 523 and if it breaks it, we can see further
upside in it and can test the level of 536
71.5, we would recommend investors
Our recommendation on Ranbaxy Labs
tock Recommendation
stock recommendation for 17/05/2011 is Ranbaxy
Ranbaxy is in uptrend for a week now and today ended up more than 5% at 518.10.
The stock is close to its 200 DMA at around 523 and if it breaks it, we can see further
the level of 536 – 552. Though, with 14-Day RSI above 70
investors to book profit frequently.
Ranbaxy Labs is BUY above 520 for the TG 525
www.capitalheight.com
capitalheight.wordpress.com
Phone- (0731)4295950
ecommendation
Ranbaxy laboratories.
Ranbaxy is in uptrend for a week now and today ended up more than 5% at 518.10.
The stock is close to its 200 DMA at around 523 and if it breaks it, we can see further
RSI above 70 at
525 – 533.
www.capitalheight.com
capitalheight.wordpress.com
Phone- (0731)4295950
Disclaimer
The information and views in this report, our website & all the service we provide are believed to be reliable, but we do not
accept any responsibility (or liability) for errors of fact or opinion. Users have the right to choose the product/s that suits
them the most.
Sincere efforts have been made to present the right investment perspective. The information contained herein is based on
analysis and up on sources that we consider reliable.
This material is for personal information and based upon it & takes no responsibility
The information given herein should be treated as only factor, while making investment decision. The report does not
provide individually tailor-made investment advice. Capitalheight recommends that investors independently evaluate
particular investments and strategies, and encourages investors to seek the advice of a financial adviser. Capitalheight shall
not be responsible for any transaction conducted based on the information given in this report, which is in violation of rules
and regulations of NSE and BSE.
The share price projections shown are not necessarily indicative of future price performance. The information herein,
together with all estimates and forecasts, can change without notice. Analyst or any person related to Capitalheight might be
holding positions in the stocks recommended. It is understood that anyone who is browsing through the site has done so at
his free will and does not read any views expressed as a recommendation for which either the site or its owners or
anyone can be held responsible for . Any surfing and reading of the information is the acceptance of this disclaimer.
All Rights Reserved.
Investment in Commodity and equity market has its own risks.
We, however, do not vouch for the accuracy or the completeness thereof. we are not responsible for any loss incurred
whatsoever for any financial profits or loss which may arise from the recommendations above. Capital height does not
purport to be an invitation or an offer to buy or sell any financial instrument. Our Clients (Paid Or Unpaid), Any third party or
anyone else have no rights to forward or share our calls or SMS or Report or Any Information Provided by us to/with anyone
which is received directly or indirectly by them. If found so then Serious Legal Actions can be taken.